SkyCell raised €57M in a funding round in Apr 2020. The company is based in Zurich, Switzerland. Investors in the round: MVM Life Science Partners. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
